Plain-English translation of NCT07812740 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term tracking study for people with rare, one-sided headache disorders—including cluster headaches, paroxysmal hemicrania, SUNCT, SUNA, and hemicrania continua. Researchers are collecting detailed information from patients like you over several years to understand these conditions better and help doctors make faster, more accurate diagnoses. You will not receive any experimental medication; instead, your doctor will continue treating you as usual while the research team gathers information about your symptoms, treatments, and quality of life.
These headache disorders are often misdiagnosed and take a long time to identify correctly, which delays proper treatment. This study exists to create a large, real-world database that will help doctors recognize these conditions faster and choose the best treatments for each patient.
You likely qualify if…
You likely don't qualify if…
You will continue to see your regular headache doctor and receive your usual treatment—nothing changes in how you are cared for. During visits every 3 to 6 months (or more often if needed), the research team will ask you detailed questions about your headaches, symptoms, treatments, and how your condition affects your daily life. You may also fill out short questionnaires about your quality of life and mood. The study will last up to 3 years for you, and researchers will use this information to build a better understanding of these rare headaches across a large group of patients.
AI-generated summary from trial data · Oct 7, 2026 · Not medical advice
Italy